A SENSIBLE SOLUTION FOR EARLY DETECTION OF DENSE BREASTS

Written by: Dr. Robert L. Bard

WHO NEEDS A DENSITY SCAN?
The Density Screening quantifies the level of tissue density (or the whiteness) and records them in various levels: 50% whiteness = not dense or minutely dense. 60% is moderately dense and 70% is highly dense, which correlates with your cancer risk. Also, 3D Scanning is a high-resolution scan allowing us to see if the skin is invaded or if the muscle and of the breast tissue is invaded by a tumor.

INDEX AREA OF SUSPICION
Initially if somebody has lumpiness or abnormal pain/discomfort in the breast, the patient guides the technician to the area of concern. An initial scan of that area is conducted and recorded. Then the full ultrasound scan over the entire breast is performed. This includes the lymph node-bearing areas under the arm and the right and left Axilla.

DIAGNOSTIC IMAGING STRATEGY
For this program, we select the predominance of the 3D Ultrasound because of its performance as a real-time, non-radiation and affordable modality. By design, today's models are highly efficient and are highly rated by more and more cancer imaging specialists around the globe- especially for dense breast scanning. It is recorded as an automated VIDEO file, capturing 250 still pictures within a 10 second scan. The dataset goes into a system that reconstructs the 3D images and each of the thousand images on each breast are then reviewed by the radiologist to focus on any abnormalities and better determine the relationship of the possible tumor with respect to the skin, the muscle, the adjacent lifts nodes and the quality of a potential lesion.

FROM SCAN TO TREATMENT
Analysis for a lesion looks for: texture/smoothness or irregular edges. Is it fluid filled? Does it have mixed tissues (some fluid & some solid tissue). Is there inflammation? Are there cancer vessels that feed a tumor noted inside? If there are cancer vessels, how many are there per unit volume? In other words, the same way we give a breast density level, a percentage of whiteness, we do the same thing with the cancer vessels that feed the tumor. So this is quantifiable. And once we have a quantifiable reading on tumor vascularity, patients who are treated with radiation, immunotherapy, chemotherapy, or any of the new focal treatments such as laser and the focused ultrasound, then you can follow the treatment success. For example, in chemotherapy, you want the percentage of tumor vessels to steadily decrease. When you do focal therapies such as freezing or laser treatments, the end point of the treatment would show a reduction to elimination of tumor vessels and how there no active blood flow going to a tumor means the treatment is complete.

SCANNING INNOVATIONS:
Decades since the advent of breast scanning technology, innovations in non-invasive diagnostic imaging provide new options in the field of early detection. These technologies directly are recognized to align with breast density screening (and are part of the Bard Breast Density Diagnostic Program):

Doppler blood flow Optical Computed Tomography (OCT) for nipple lesions
Contrast enhanced ultrasound vascularity Reflectance Confocal Microscopy (RCM) for dermal invasion
3D Vessel Density Histogram Hybrid Mammo Imaging Fusion
4D Volumetric Density Histogram Thermo-sensor
Strain and shear wave tissue Elastography Trans Illumination
3 T MRI Near Infrared Specroscopy

Hybrid imaging refers to combining diagnostic modalities to assess disease and monitor therapy. A useful combination of options is the tumor vessel flow density to assess aggression and treatment progress. Similarly, tissue elastography is useful for border detection of malignant masses.

THE DENSE BREAST SCAN MOVEMENT
7/8/2021- A wave of recognized medical sites, journals and reports are now indicating that dense breast tissue increases the risk of developing breast cancer and often masks a tumor from being seen on the mammogram since dense tissue is white and cancerous tissue is also white. Mammograms are the standard screening test for breast cancer, however, in the 21st Century, ultrasound non invasive imaging is the preferred exam for dense “lumpy” mammary disease.

The 1st World Conference of Breast Ultrasound in Philadelphia (1979) recognized ultrasound superiority in dense breast diagnostics but the density level was never quantified until recently. Mammography assessment of breast density is graded into four categories. Mammographers readily admit that these levels are subjective at best and technical factors such as mammary tissue compression and x-ray voltage/amperage dramatically influence the darkness or whiteness of the image

• Where is Ultrasound most useful?
Mammograms of dense (lumpy) breasts have an elevated miss rate since tumors are white and dense breast tissue is white. Cancer tumors on ultrasound appears as black on a white background. Experience shows that ultrasound is typically more effective and accurate in thin women with dense breasts.

• What is Doppler sonogram technology?
Doppler imaging shows a map of blood vessels like the Doppler weather map shows hurricanes. More blood vessels means more aggressive tumors. Decrease in vessels means clinical improvement. The testing is non invasive.

• What is 4D volumetric density histogram imaging?
3 D imaging takes 200 pictures in 5 second and sees invasive cancers as small as 3 mm. 4D shows the imaging in real time of the dense tissue. Computer analysis gives a quantitative measure of the whiteness of the volume which assesses cancer risk.

• How is 3D/4D Doppler imaging used?
This is currently used to predict complete treatment response in patients undergoing chemotherapy and/or radiation therapy according to the 2021 Journal of Ultrasound. Cessation of tumor blood flow documents therapeutic success.

• Can a negative test be used to reduce biopsies?
The finding of a simple cyst or suspicious area on a mammogram (“lumpy” or fibrocystic region) means most patients can be followed up in 6 months or opt for a tiny small needle aspiration instead of a biopsy. The accuracy for malignancy diagnosis is 95%. Suspicious lymph nodes are also analyzed.

 

What Does It Mean to Have Dense Breasts?

Source: CDC.gov

A mammogram shows how dense your breasts are. When you get the results of your mammogram, you may also be told if your breasts have low or high density. Women with dense breasts have a higher risk of getting breast cancer.

PARTS OF THE BREAST
A woman’s breast has three kinds of tissue: FIBROUS TISSUE holds the breast tissue in place. GLANDULAR TISSUE is the part of the breast that makes milk, called the lobes, and the tubes that carry milk to the nipple, called ducts. Together, fibrous and glandular tissue are called fibroglandular tissue. FATTY TISSUE fills the space between the fibrous tissue, lobes, and ducts. It gives the breasts their size and shape.

BREAST CANCER RISK: Women with dense breasts have a higher chance of getting breast cancer. The more dense your breasts are, the higher your risk. Scientists don’t know for sure why this is true. Breast cancer patients who have dense breasts are not more likely to die from breast cancer than patients with non-dense (fatty) breasts.

* * * SAVE THE DATE * * *
On July 27-29, we have special limited access to the latest breast scanning technology (CLICK TO SEE 3min VIDEO on the GE Invenia ABUS)

 

On July 27-29, Bard Diagnostic Imaging is offering a comprehensive DENSE BREAST SCREENING DAY, employing an array of imaging advancements dedicated to the visibility of dense breast tissue and cancer early detection. This special program is dedicated to supporting dense breasted patients by first identifying one's actual breast density (through a density assessment scan) to establish a base line for the full diagnostic study (est. 15-20 minutes per patient).

For those with any level of breast density, a major concern is the rate of possible cancers that may be missed from to potential misreadings of a mammogram. It is clinically imperative to have a second opinion with the breast sonogram in areas that are more suspicious. A second look of the dense breast area with 3D scanning technology consists of two parts: first is the regular 3D electronic sweep, which gives you a volumetric tissue study. The next is the 4D real-time automated scan, which focuses on the area of concern and the most dense part of the tissue.

Mammogram imaging tends to represent dense tissue as "white" as it also does a small tumor (associate this with a "Polar Bear in a Snowstorm"). Medical interpreters look upon the white tissue as the area where mammograms could miss looming cancers. This is where the 3D and 4D ultrasound imaging comes in; we can now read the density of the tissue which aligns with the potential risk of cancer and navigate through and around the breast giving us the ability to disseminate tissue from tumor. (Read about the data and elevated risk of cancer in dense breasted patients in cancer.org). Through the latest imaging innovation, we have the means to quantify and mitigate this risk by detecting and identifying the "white level" and scanning with the computerized analysis of the volume of suspicious tissue.

Make an appointment today @ 212-355-7017. Slots are limited.

BACK TO HOME PAGE
 

 

Three Staging Options for Advanced Digital Breast Imaging
Advanced sonogram technology provides accurate use of sound waves to produce real-time images of the inside of the body. It is used as a complement to find anomalies and help diagnose the causes of pain, swelling and infection in the body’s internal organs while allowing the diagnostician the ability to zoom and ‘travel’ deep into the body for maximum exploration. Digital Imaging technology is also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. Imaging solutions such as high-powered Sonograms, Spectral Doppler, sonofluoroscopy, 3D/4D Image Reconstruction and the Spectral Doppler are safe, noninvasive, and does not use ionizing radiation. They also have the ability to provide early detection scans. ** Three STAGING OPTIONS are available depending on the patient’s current needs- to be discussed with practitioner prior to or during examination.

Option 1
Option 2
Option 3
BREAST only
Typically performed for patients either self-identifying anomalies (bumps) for the first time and/or are seeking a second opinion + may have a family history of breast cancer (or other related cancers related to the breast)
BREAST & AXILLAE
This option scans the breast and the shoulder through which vessels and nerves enter and leave the upper arm; a person's armpit. This option is recommended for anyone who may be currently Undergoing cancer treatment... also anyone who has recently (prior to 5 years) undergone a mastectomy since it detects unsuspected metastatic disease
BREAST, DUCTS &
LYMPH NODES

For a patient who is at high risk for developing a cancer or requires advanced confirmation of a current tumor treatment protocol since the 3D/4D computer analysis verifies the success of the therapy in a quantitative analysis by the unique Doppler histogram technology

Technology applied:
SONOGRAM

Technology applied:
 SONOGRAM
 SPECTRAL DOPPLER

Technology applied:
 SONOGRAM-HIGH RESOLUTION
 SONOFLUOROSCOPY
 3D/4D IMAGE RECONSTRUCTION
 SPECTRAL DOPPLER


SONOGRAM: Seek subdermal masses, breast lumps, tumor growths, fluid-filled cysts, nodes or hematoma. Sonography can be performed in multiple scan planes with real time 3-D image analysis with power and spectral Doppler flows.
SONOFLUOROSCOPY: of intra/subdermal soft tissues is to be performed in multiple scan planes with varying transducer frequencies.
3D/4D IMAGE RECONSTRUCTION: For any lesions that are homogeneous echogenic and well marginated on 3D and 4D computer histogram analysis.
SPECTRAL DOPPLER: Search for hyperemia of any lesions. Power Doppler will show normal flows in the adjacent arteries/veins. Spectral flows will show normal tri-phasic waveforms. Search for any peripheral lesion abnormalities or focal vascularity.

For more information on Advanced Digital Breast Imaging, contact us at: 212.355.7017



BREAST CANCER SCREENING REGIMEN
The current standard in screening for breast cancer is mammography. However, this imaging tool misses some breast tumors, especially in women with dense breasts. Published data suggests that sonography can play an important role in detecting tumors that mammography misses. In fact, over 94% of cancers seen only on ultrasound were invasive tumors with average size of 10 mm, and in the studies where staging was detailed, 91% were node negative, meaning it had not spread and complete cure was possible due to early detection.

Power Doppler Sonography adds increased accuracy to breast imaging evaluation over ordinary ultrasound because it shows higher blood flow speeds, often a sign of cancerous activity in the breast. Studies have shown that suspicious blood flow identified by pre-surgery Power Doppler scans corresponds very well with the size, location and aggression of actual tumors that are then surgically removed. Thus, Power Doppler brings an important clinical dimension to breast cancer detection. 3D sonography clearly shows tumor margins and 3D Doppler affords an index of cancer aggression and metastatic potential.

 

 

Breast Sonograms and Ultrasound offers the following advantages:
• Highest accuracy in dense (lumpy, cystic) breasts
• Non-invasive-no radiation exposure
• Cost effective
• Can distinguish cysts (fluid-filled masses) from cancerous tumors without needle sampling
• Ease of image guidance for breast biopsy

Women who should consider ultrasound scanning of the breast include those at risk of breast cancer because of personal or family history and the presence of fibrocystic (dense) breast tissue which increases cancer risk by 400%.

(SEE COMPLETE DETAILS)

 

Breast Imaging & Advanced Screening Programs
for New York Women's Groups & Organizations

LET'S UNITE IN THE FIGHT! In the spring of 2018, Bard Cancer Diagnostics (BCD) recently partnered with AWARENESS FOR A CURE and The NY Cancer Resource Alliance to join the battle against breast cancer by establishing a foundation-based Cancer Screening & Monitoring program for all members of non-profit Breast Cancer Organizations and NY-based Women's Groups. This unique program works with all major health providers to bring the most up-to-date technologies and alternative diagnostic solutions (including "2nd Opinion" reviews) and regularly scheduled monitoring and EARLY DETECTION SCANS - all at a significantly reduced rates. BCD also raffles off an Advanced Comprehensive 3/D & 4/D Diagnostic Packages for Breast, Skin and Lung Cancers for qualified organizations- a $2200 value. Inquire about our programs for Women's orgs: email bardcancercenter1@gmail.com
or call 631-920-5757. (vid1)

FAQ about Non-Invasive Sonic Technology & the Future of Cancer Biopsies

Since 1973, Dr. Bard established global recognition in the medical field through his contributions in the advancement of cancer diagnostic innovations. His special use of advanced imaging technologies are widely praised as the painless alternative and a more accurate innovation as well as a much faster solution for acquiring results over surgical biopsies. For the patient, it's a world of difference and immediate peace of mind when the 3D imaging establishes the diagnosis during the examination as you literally see the pictures in front of you in real time.

Q: How accurate is Advanced Sonography in identifying cancers? (open)

Q: Give us an example of your 4D Scan's accuracy over conventional diagnostic methods? (open)

Q: What types of cancers are most commonly captured with this technology? (open)

Q: How can digital scanning be instrumental in Early Detection? (open)

Q: What are the benefits of using the Doppler Ultrasound imaging for BREAST CANCER? (open)

Q: Why scan the lymph nodes in the axillae? (open)

Q: What are the most recent upgrades in the cancer imaging industry? (open)

Q: Can this technology be useful in other health issues and disorders? (open)

MPR-TV reports on Advanced Cancer Doppler Imaging. Meet Dr. Robert L. Bard (award-winning cancer diagnostician and expert imaging specialist) and see him break down the difference between a benign tumor and a fully-blown cancerous cell- and how using his advanced 3D and 4D Doppler technology makes all the time-saving difference in getting an accurate study.

 


SELF-AWARENESS IS JOB 1!

Many routine imaging procedures can assure people that they are at risk for a disease or catastrophic medical event: heart scans, virtual colonoscopies, and lung screening are a few examples of ways to encourage healthy choices (nutrition, supplements, exercise, stress management, etc.) by reinforcing them. BARD CANCER DIAGNOSTICS is founded on the commitment to explore and implement the latest diagnostic technologies as a means of building the proper treatment strategy of many types of cancers. We also specialize in PREVENTION solutions for our patients who strive to maintain a health-conscious lifestyle as well as those who are at increased risk of certain diseases (hereditary factors or environmental exposure to toxic substances) by confirming that their efforts to prevent disease are working.

COMPUTERIZED 3D DOPPLER HISTOGRAM ANALYSIS
Using state-of-the-art equipment, Dr. Bard’s practice offers unique forms of sonography to evaluate blood flow related to tumor activity and to identify areas of suspicion. More tumor vessels signifies more aggressive disease. 3D & 4D analyses are non-invasive and rapid with results available to the patient during the visit. Patients in need of reassurance and world class imaging come from all countries for cancers of the prostate, breast, skin, thyroid and melanoma.

PINK-SMART NEWS IS COMING BACK! In April of 2021, we are publishing new interviews, articles, videos and other educational must-haves for survivors, patients and the community that is breast cancer. With support from some of the top leading foundations, Pink-Smart News will be presented by some of the who's who in Oncology, Immunology, cancer radiology and other areas that support the advancement of cancer care. See archived articles from Pink-Smart News

 


ABOUT OUR PROGRAM

As of Jan '18, Dr. Robert Bard spearheaded a partnership with a host of cancer educators, medical practitioners and non-profit foundations (allied under AwarenessforaCure.org) to form a public resource program to aid in the advancement of the public's understanding about self-preservation from cancer and other chronic diseases. EARLY DETECTION & PREVENTION is a global health movement that promotes a higher regard for "clean living" - from toxins and a toxic lifestyle. Our program consists of four main efforts: EDUCATION, COMMUNITY CONNECTION, CURRENT NEWS & CLINICAL RESOURCES. EARLY DETECTION & PREVENTION brings the empowerment of wellness through group seminars, videos and the distribution of current articles & newsletters published/shared to all the major cancer charities and their members. 

For more information or to subscribe to our EARLY CANCER DETECTION & PREVENTION PROGRAM newsletter, contact Bard Cancer Diagnostics today at: 212.355.7017 - or email us at: bardcancercenter1@gmail.com. Bard Cancer Diagnostics is located at 121 E. 60th St. Suite #6A New York, NY 10022. Visit the complete website: www.CancerScan.com


EARLY DETECTION SAVES LIVES!
According to the World Health Organization, early detection of cancer greatly increases the chances for successful treatment. In the ongoing battle against cancer, it is common knowledge that most cancers in their early stages are far more likely to be treated with positive results. Moreover, a thorough checkup of one's physiological analyses, heredity review and personal data gathering (from blood & dna tests) are all strong info-gatherings for early warning signs that someone may be a candidate for cancer. PROACTIVE tasking starts from AWARENESS, EDUCATION & REGULAR SCREENINGS. The right attitude of self-preservation and an appreciation for longevity is lesson #1. Pursuing a balanced lifestyle covering all the bases of nutrition, exercise, sleep, detoxing and de-stressing is also part of an overall plan for better quality of life.

 

 

 

Copyright © 2018- Bard Diagnostic Publishing. All Rights Reserved.